ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC).
暂无分享，去创建一个
B. Monk | A. Oza | R. Coleman | Susana Banerjee | N. Colombo | A. Oaknin | D. O’Malley | E. Van Nieuwenhuysen | M. Fabbro | J. Pachter | R. Grisham | K. Moore | L. Denis | Gloria Patrick | Lorna Leonard